Cambridge Advisors Inc. Invests $222,000 in Gilead Sciences, Inc. (NASDAQ:GILD)
Cambridge Advisors Inc. acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,650 shares of the biopharmaceutical company’s stock, valued at approximately $222,000. Several other hedge funds […]
25 Oct 11:39 · The Markets Daily